Jove
Visualize
Contact Us

Related Concept Videos

Vaccinations01:51

Vaccinations

45.8K
Overview
45.8K
Cross-reactivity00:42

Cross-reactivity

31.7K
Overview
31.7K
Viral Recombination00:57

Viral Recombination

23.9K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
23.9K
Cancer Vaccines01:30

Cancer Vaccines

554
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
554
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

461
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
461
Viral Mutations00:36

Viral Mutations

34.6K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
34.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The impact of software and criteria on the selection of best-fit nucleotide substitution models for molecular evolutionary genetic analysis.

PloS one·2025
Same author

The evolutionary and transmission dynamics of HIV-1 CRF08_BC.

PloS one·2024
Same author

Optimizing ancestral trait reconstruction of large HIV Subtype C datasets through multiple-trait subsampling.

Virus evolution·2023
Same author

The emergence and transmission dynamics of HIV-1 CRF07_BC in Mainland China.

Virus evolution·2022
Same author

Concerns on the multiple nomenclature systems for SARS-CoV-2.

Journal of medical virology·2021
Same author

Response to comments on "Cross-species Transmission of the Newly Identified Coronavirus 2019-nCoV" and "Codon bias analysis may be insufficient for identifying host(s) of a novel virus".

Journal of medical virology·2020
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Oct 9, 2025

Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research
06:08

Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research

Published on: September 8, 2023

1.4K

Omicron: Call for updated vaccines.

Xingguang Li1,2

  • 1Hwa Mei Hospital, University of Chinese Academy of Sciences, Ningbo, China.

Journal of Medical Virology
|December 20, 2021
PubMed
Summary
This summary is machine-generated.

The Omicron variant may arise from vaccinated individuals, prompting research into vaccine roles in viral evolution. Development of effective, lifelong, one-dose vaccines is urgently needed.

Keywords:
COVID-19SARS-CoV-2VOCsVOIs

More Related Videos

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

3.0K
Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses
05:49

Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses

Published on: November 21, 2023

1.9K

Related Experiment Videos

Last Updated: Oct 9, 2025

Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research
06:08

Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research

Published on: September 8, 2023

1.4K
Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

3.0K
Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses
05:49

Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses

Published on: November 21, 2023

1.9K

Area of Science:

  • Virology
  • Immunology
  • Vaccinology

Background:

  • The emergence of SARS-CoV-2 variants, such as Omicron, poses a significant challenge to global pandemic control.
  • Vaccination strategies, including mRNA- and non-mRNA-based vaccines, are crucial in managing the pandemic but may also influence viral evolution.

Purpose of the Study:

  • To evaluate the potential role of mRNA- and non-mRNA-based vaccines in the generation of novel SARS-CoV-2 variants of concern (VOCs) and interest (VOIs).
  • To assess the implications of breakthrough infections and vaccine-induced immunity on viral mutation and immune evasion.

Main Methods:

  • Systematic evaluation of vaccine types (mRNA vs. non-mRNA) and their potential link to SARS-CoV-2 variant generation.
  • Analysis of breakthrough infections in vaccinated individuals to understand immune response and viral evolution.

Main Results:

  • The Omicron variant may have originated in a chronically infected, vaccinated individual, highlighting a potential pathway for viral evolution.
  • Booster vaccinations may offer temporary protection, but frequent boosting raises health concerns.

Conclusions:

  • Further research is needed to understand the complex interplay between vaccines, immune responses, and the evolution of SARS-CoV-2 variants.
  • There is an urgent need for the development of highly effective, one-dose vaccines offering lifelong protection against current and future SARS-CoV-2 variants.